Recurrent Pancreatic Carcinoma Completed Phase 2 Trials for Pelareorep (DB17284)

Also known as: Pancreatic carcinoma recurrent / Pancreas carcinoma recurrent / Pancreatic cancer recurrent

IndicationStatusPhase
DBCOND0043478 (Recurrent Pancreatic Carcinoma)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01280058Carboplatin and Paclitaxel With or Without Viral Therapy in Treating Patients With Recurrent or Metastatic Pancreatic CancerTreatment